帳號:guest(3.129.243.23)          離開系統
字體大小: 字級放大   字級縮小   預設字形  

詳目顯示

以作者查詢圖書館館藏以作者查詢臺灣博碩士以作者查詢全國書目勘誤回報
作者(中):丁宇星
作者(英):Ding, Yu-Xing
論文名稱(中):形塑動物保健行業在各國的藥品註冊策略 : 以中國為例
論文名稱(英):Shaping Regulatory Affairs Strategy in Animal Healthcare Industry at a Country Level: The Case of China
指導教授(中):冷則剛
指導教授(英):Leng, Tse-Kang
口試委員:吳文傑
劉秀明
口試委員(外文):Wu, Jack
Liu, Sandra
學位類別:碩士
校院名稱:國立政治大學
系所名稱:國際經營管理英語碩士學位學程(IMBA)
出版年:2018
畢業學年度:107
語文別:英文
論文頁數:83
中文關鍵詞:動物保健規制策略動物藥品中國
英文關鍵詞:Animal healthRegulatory strategyVeterinary medicinal productChina
Doi Url:http://doi.org/10.6814/THE.NCCU.IMBA.041.2018.F08
相關次數:
  • 推薦推薦:0
  • 點閱點閱:88
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:1
  • gshot_favorites title msg收藏:0
The fast-growing global demand for livestock-derived products and pet health care has driven the animal healthcare industry to develop safe, efficacious, and high-quality veterinary medicinal products. The commercialization of most veterinary medicinal products, similar to human medicine, requires the marketing authorization from regulatory authorities. However, the complexities of regulatory environment and inconsistent regulatory requirement at different markets have still been a hurdle for multinational companies to rapidly bring new products to the market, especially to China. The objective of this study is to provide a systemic analysis on China’s regulatory landscape as well as to help animal healthcare firms develop a well-structured and robust in-country regulatory affairs strategy in China.We started from examining existing regulatory challenges and conducting gap analysis on currently proposed solutions to regulators and industry. The roadmap comprising key driving forces and elements to the regulatory approval in China as well as potential roadblocks were analyzed and constructed. The proposed “Schematic of Regulatory Affairs Process” offers a practical approach for multinational animal healthcare firms to develop the most rewarding regulatory affairs strategy in China via capturing required forces driving to the regulatory approval of veterinary medicinal product.
1. Introduction ......1
2. Review.....4
2.1. Overview of Animal Healthcare (AH) Industry ....4
2.2. Regulatory Landscape for Animal Healthcare Product ....8
2.2.1. Regulatory Body and Regulatory Framework....9
2.2.2. Key Animal Healthcare Stakeholder ......14
2.2.3. Registration Process and Timeline ......17
2.2.4. Regulatory Requirement and Assessment Approach ....22
2.3. Regulatory Challenge and Impact on Animal Healthcare Products .....26
2.3.1. at a Global Level .......26
2.3.2. at a Regional Level .......29
2.3.3. at a Country Level .......34
2.4. China Focus ......39
3. Gap Analysis ........42
3.1. on Proposed Solutions to Regulatory Challenges for Regulators ..........43
3.2. on Proposed Solutions to Regulatory Challenges for AH Industry ......46
4. Proposed Solution ........49
iv
4.1. Roadmap to Regulatory Approval in China .....50
4.2. Roadblocks to Regulatory Approval in China .....52
4.3. “Schematic of Regulatory Affairs Process” to Regulatory Approval........57
4.3.1. Regulatory Landscape Analysis .......57
4.3.2. Creating Forces to Regulatory Approval .....62
4.3.3. Capturing Forces to Regulatory Approval ......64
4.3.4. Sustaining Forces to Regulatory Approval ......68
5. Conclusion .....69
6. Reference ......73
[1] Hunter, R. P., Shryock, T. R., Cox, B. R., Butler, R. R., Hammelman, J. E. [J]. Overview of the animal health drug development and registration process: an industry perspective. Future Med. Chem., 2011, 3(7): 881-886.
[2] AnimalHealthEurope. How veterinary medicines are made [EB/OL]. https://www.animalhealtheurope.eu/infographics.html#gallery-6, 2016-01-01/2017-01-02.
[3] VICH. Organizational Charter of VICH [EB/OL]. https://vichsec.org/process/the-ogranisational-charter.html, 2018-01-01/2017-01-06.
[4] HealthforAnimals. About us [EB/OL]. http://www.healthforanimals.org/aboutus/about-us.html, 2016-01-01/2017-01-06.
[5] OIE. American Committee Veterinary Medicinal Products [EB/OL]. http://wahis2-devt.oie.int/dev-rramericas/index.php?id=171, 2017-01-01/2017-01-04.
[6] ANFPVP. ASEAN Cooperation on Veterinary Products [EB/OL]. http://vichsec.org/outreach-forum/index.php?option=com_attachments&view=attachments&task=attachment&id=943, 2014-6-25/2017-1-10.
[7] Argento, E. Case Study on regional harmonization initiatives in America [EB/OL]. https://www.healthforanimals.org/component/attachments/?task=download&id=244:Case-Study-on-Regional-Harmonization-Initiatives-in-Latin-America, 2016-01-01/2017-01-15.
[8] Healthforanimals. Global survey reveals common barriers to animal health around the world [EB/OL]. http://www.healthforanimals.org/resources-and-events/resources/press-releases/151-press-release-global-survey-reveals-common-barriers-to-animal-health-around-the-world.html, 2016-06-08/2017-01-12.
[9] AnimalPharm. Animal health industry trends 2016 webinar [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP009775/Animal-health-industry-trends-2016-webinar, 2016-01-29/2017-01-15.
[10] Harvey J. William Blair details a stable US market dominated by the 'big four' [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP013656/William-Blair-details-a-stable-US-market-dominated-by-the-big-four, 2018-02-13/2018-03-02.
[11] Research and Markets. Global Animal Healthcare Market 2017-2025 - A $53 Billion Market Potential [EB/OL]. https://www.prnewswire.com/news-releases/global-animal-
75
healthcare-market-2017-2025---a-53-billion-market-potential-300577550.html, 2018-01-04/2018-03-05.
[12] Statista. Global animal health market size from 2002 to 2016 (in billion U.S. dollars) [EB/OL]. https://www.statista.com/statistics/260185/global-animal-health-market/, 2017-10-30/2017-11-02.
[13] Schaefer S. Puppies over pills: Pfizer spin out Zoetis shines in biggest IPO since Facebook [EB/OL]. https://www.forbes.com/sites/steveschaefer/2013/02/01/puppies-over-pills-pfizer-spinoff-zoetis-shines-in-biggest-ipo-since-facebook/#29cadd6c4f8a, 2013-02-01/2017-03-05.
[14] Harvey J. Animal health awaits the return of the big start-up investment [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP013610/Animal-health-awaits-the-return-of-the-big-startup-investment, 2018-02-05/2018-03-16.
[15] Harvey J. New Animal Pharm database suggests scope of animal health funding is widening [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP013134/New-Animal-Pharm-database-suggests-scope-of-animal-health-funding-is-widening, 2017-10-20/2018-01-20.
[16] Alaix J.R. Zoetis: the world leader in animal health [EB/OL]. https://investor.zoetis.com/sites/zoetis.investorhq.businesswire.com/files/event/additional/Zoetis_at_William_Blaire_Conference_6.10.15.pdf, 2015-06-10/2017-10-03.
[17] Pwc. Animal Health: Strategy playbook for an evolving industry [EB/OL] https://docplayer.net/19346825-Animal-health-strategy-playbook-for-an-evolving-industry.html, 2015-08-01/2017-02-06.
[18] Future Market Insights Global and Consulting Pvt. Ltd. Animal Healthcare Market Size to be US$ 54,548.0 Mn by 2027 | CAGR: 4.3% - Future Market Insights [EB/OL]. https://globenewswire.com/news-release/2017/12/08/1250212/0/en/Animal-Healthcare-Market-Size-to-be-US-54-548-0-Mn-by-2027-CAGR-4-3-Future-Market-Insights.html, 2017-12-08/2018-02-05.
[19] United Nations. World Population Prospects: The 2017 Revision [EB/OL]. https://www.un.org/development/desa/publications/world-population-prospects-the-2017-revision.html, 2017-06-21/2018-02-13.
[20] The World Bank. Middle Income [EB/OL]. https://data.worldbank.org/income-level/middle-income, 2016-12-31/2018-01-30.
[21] GlobeNewswire. Global Animal Health Market Forecast to 2020 - Inclining Pet Adoption and Awareness among Animal Husbandry Farmers to Foster Growth [EB/OL].
76
https://globenewswire.com/news-release/2017/03/13/935338/0/en/Global-Animal-Health-Market-Forecast-to-2020-Inclining-Pet-Adoption-and-Awareness-among-Animal-Husbandry-Farmers-to-Foster-Growth.html, 2017-03-13/2017-05-23.
[22] Harvey J. Jeff Simmons pinpoints the credibility crossroads animal health finds itself facing [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP013670/Jeff-Simmons-pinpoints-the-credibility-crossroads-animal-health-finds-itself-facing, 2018-02-15/2018-06-21.
[23] Zoetis. Growing industry [EB/OL]. https://www.zoetis.com/animal-health/growing-industry.aspx, 2015/2017-11-02.
[24] Vetnosis. Storm Forecasts: 2017-26 [EB/OL]. http://vetnosis.com/pdfs/STORM_2017_web.pdf, 2017-06/2017-09-21.
[25] Future Market Insights Global and Consulting Pvt. Ltd. Animal healthcare market global industry analysis and opportunity assessment 2015-2020 [EB/OL]. https://www.futuremarketinsights.com/reports/animal-healthcare-market, 2017-09-19/2017-05-01.
[26] AnimalPharm. Animal health industry trends 2016 webinar [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP009775/Animal-health-industry-trends-2016-webinar, 2016-01-29/2017-05-15.
[27] Harvey J. Strong market growth in Europe stems from ongoing adoption of vaccines [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP013649/Strong-market-growth-in-Europe-stems-from-ongoing-adoption-of-vaccines, 2019-02-12/2018-03-15.
[28] Eli Lilly. Eli Lilly and Company Investment Community Meeting [Z]. 2015-12-08/2017-03-19.
[29] Markets and Markets. Asia-Pacific Animal Health Market worth 20.25 Billion USD by 2021 [EB/OL]. https://www.marketsandmarkets.com/PressReleases/asia-pacific-animal-health.asp, 2017/2018-04-01.
[30] Statista. Distribution of global animal health care market volume in 2015, by region [EB/OL]. https://www.statista.com/statistics/258208/animal-health-market-volume-by-region-2012/, 2016/2017-05-10.
[31] Statista. Distribution of global animal health care market volume in 2016, by region [EB/OL]. https://www.statista.com/statistics/258208/animal-health-market-volume-by-region-2012/, 2017/2017-05-10.
77
[32] Grand View Research, Inc. Companion Animal Health Market Size Worth $20.9 Billion by 2025 [EB/OL]. https://www.marketwatch.com/press-release/companion-animal-health-market-size-worth-209-billion-by-2025-grand-view-research-inc-2018-01-08, 2018-01-08/2018-04-23.
[33] MSD Animal Health. AMR and animal agriculture Perspective from a global animal health company [EB/OL]. https://epha.org/wp-content/uploads/2016/07/17.Oostenbach_EPHA_presentation_20160908_final.pdf, 2016-09-08/2018-04-20.
[34] Statista. Distribution of global animal health care market by product group in 2016 [EB/OL]. https://www.statista.com/statistics/258203/animal-health-market-growth-by-product/, 2017/2018-02-21.
[35] Statista. Distribution of global animal health care market by region in 2015 [EB/OL]. https://www.statista.com/statistics/258208/animal-health-market-volume-by-region-2012/, 2017/2018-02-21.
[36] Harvey J. Animal health industry rankings 2017: One big Boehringer-size change masks ongoing vibrancy across big players [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP014021/Animal-health-industry-rankings-2017-One-big-Boehringersized-change-masks-ongoing-vibrancy-across-bi, 2018-04-30/2018-06-30.
[37] Harvey J. Review 2016: Industry reins in spending as bolt-on acquisitions dominate [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP009790/Review-2016-Industry-reins-in-spending-as-bolton-acquisitions-dominate, 2017-01-09/2017-07-13.
[38] Harvey J. Important Animal Health H&A 1995-2015 [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/, 2016-04-07/2017-05-22.
[39] Harvey J. Boehringer becomes top spender on animal health R&D [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP014068/Boehringer-becomes-top-spender-on-animal-health-RD, 2018-05-09/2018-06-01.
[40] Harvey J. Industry calls for change to tough Asian regulatory system [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP007850/Industry-calls-for-change-to-tough-Asian-regulatory-system, 2014-11-26/2017-03-03.
[41] 正典生物. 中国兽药市场年增长额超30亿元,疫苗仍是最大增长[EB/OL]. https://www.xuehua.us/2018/06/28/中国兽药市场年增长额超30亿元,疫苗仍是最大增长/, 2018-06-28/2018-07-01.
78
[42] Harvey J. Zoetis and Merial shed light on China: 'The growth engine for animal health' [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP011100/Zoetis-and-Merial-shed-light-on-China-The-growth-engine-for-animal-health, 2016-11-14/2017-12-02.
[43] Zoetis Inc. Zoetis to Expand Animal Vaccine Research and Manufacturing in Suzhou, China [EB/OL]. https://news.zoetis.com/press-release/events/zoetis-expand-animal-vaccine-research-and-manufacturing-suzhou-china, 2018-04-16/2018-05-31.
[44] Harkell L. Fast-growing but fragmented: A guide to China's animal health market and firms [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP008488/Fastgrowing-but-fragmented-A-guide-to-Chinas-animal-health-market-and-firms, 2015-04-27/2017-06-12.
[45] Bureau of Veterinary, Ministry of Agriculture, P.R. China. Animal Health in China [EB/OL]. http://jiuban.moa.gov.cn/sjzz/syj/kjybz/201310/P020131024580359130205.pdf, 2009/2017-06-30.
[46] 陈瑞祥. 国际动物用药品检验登记[EB/OL]. https://vettech.nvri.gov.tw/Appendix/publication/976.pdf, 2015/2017-03-23.
[47] US FDA. About the Center for Veterinary Medicine (CVM) [EB/OL]. https://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CVM/default.htm, 2018-8-29/2018-04-28.
[48] USDA. Veterinary Biologicals [EB/OL]. https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/veterinary-biologics, 2017-05-30/2017-06-28.
[49] US FDA. Safe Use of Flea and Tick Products in Pets [EB/OL]. https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm169831.htm, 2014-06-23/2017-05-23.
[50] US FDA. Animal Products FDA Regulates [EB/OL] https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm268125.htm, 2018-10-26/2018-05-14.
[51] USDA. APHIS Organization [EB/OL]. https://www.aphis.usda.gov/aphis/banner/aboutaphis/sa_aphis_organization/ct_aphis_organization, 2016-09-12/2017-07-18.
[52] EMA. Marketing authorization [EB/OL]. https://www.ema.europa.eu/en/veterinary-regulatory/marketing-authorisation, 2017-04-05/2017-06-30.
79
[53] EMA. About us [EB/OL]. https://www.ema.europa.eu/en/about-us, 2017-04-05/2017-06-30.
[54] Madival C.D., Balamuralidhara V., Kumar P., Ramkishan A. Animal Healthcare products in China A Regulatory Landscape [EB/OL]. http://animalhealthmedia.com/animal-healthcare-products-china-regulatory-landscape/, 2016-07-10/2017-03-01.
[55] 中华人民共和国农业部公告第2599号. 兽药注册评审工作程序[S]. 2017-10-31/2018-02-03.
[56] OIE. International Standards [EB/OL]. http://www.oie.int/standard-setting/overview/, 2018/2018-02-20.
[57] OIE. The VICH Outreach Forum [EB/OL]. http://www.oie.int/scientific-expertise/veterinary-products/vich-outreach-forum/, 2018/2018-02-20.
[58] OIE. OIE PVS Pathway [EB/OL]. http://www.oie.int/solidarity/pvs-pathway/, 2018/2018-02-20.
[59] USDA. Codex Alimentarius Commission [EB/OL] https://www.fsis.usda.gov/wps/portal/fsis/topics/international-affairs/us-codex-alimentarius/Codex+Alimentarius+Commission, 2018-08-06/2018-01-23.
[60] HealthforAnimals. Global Benchmarking Survey 2015 Report [EB/OL]. https://healthforanimals.org/resources-and-events/resources/publications/150-global-benchmarking-survey-2015-report.html, 2016-06-28/2017-06-30.
[61] BioBridge Ltd. HealthforAnimals Global Benchmarking Survey 2015 – China [R]. HealthforAnimals, 2016: 1-34.
[62] 中华人民共和国农业部第44号. 兽药注册办法[S].
[63] 中华人民共和国农业部公告第442号. 兽药注册资料要求[S].
[64] 农业部公告第683号. 兽用生物制品试验研究指导原则[S].
[65] HealthforAnimals. Global survey reveals common barriers to animal health around the world [EB/OL]. https://healthforanimals.org/resources-and-events/resources/press-releases/151-press-release-global-survey-reveals-common-barriers-to-animal-health-around-the-world.html, 2016-06-28/2017-07-14.
[66] HealthforAnimals. Animal Health industry calls for greater collaboration between national governments [EB/OL]. https://healthforanimals.org/resources-and-events/resources/press-releases/162-animal-health-industry-calls-for-greater-collaboration-between-national-governments.html, 2016-11-21/2017-07-14.
[67] Harvey J. Global Benchmarking survey shows regulatory dissatisfaction is a worldwide trend [EB/OL].
80
https://animalpharm.agribusinessintelligence.informa.com/AP010479/Global-Benchmarking-survey-shows-regulatory-dissatisfaction-is-a-worldwide-trend, 2016-06-30/2017-07-15.
[68] Harvey J. World Bank highlights regulatory deficiencies in emerging markets [EB/OL]. https://iegvu.agribusinessintelligence.informa.com/AP011145/World-Bank-highlights-regulatory-deficiencies-in-emerging-markets, 2016-11-23/2017-10-15.
[69] Dawson T. Balance required between regulation and innovation for novel vet meds [EB/OL]. http://www.triveritas.com/wp-content/uploads/2016/02/AP-Regulation-Innovation-for-Novel-Vet-Meds-May2015.pdf, 2015-05-01/2017-10-16.
[70] Sarvaas C.d.M. VICH. Industry: trends, concerns, hopes, and ideas [EB/OL]. https://www.vichsec.org/component/attachments/attachments/1273.html?task=attachment, 2015-10-28/2017-10-14.
[71] Kansas States University. Challenges and Opportunities in Animal Health Regulatory Affairs – A compilation of industry roundtable discussions. [EB/OL]. https://olathe.k-state.edu/professional-dev/workshops/regulatory-affairs/documents/sept17/Roundtable%20Summary%20Final%2010-20-2017.pdf, 2017-10-20/2018-02-02.
[72] US FDA. Regulation of Novel New Animal Drugs [EB/OL]. https://olathe.k-state.edu/professional-dev/workshops/regulatory-affairs/past-seminars/cvm-regulatory-challenges.html, 2017-12-07/2018-03-01.
[73] Kallo E. M. Enabling the Business of Agriculture (EBA) – Veterinary Medicines for Livestock 2016 [EB/OL]. https://healthforanimals.org/component/attachments/?task=download&id=239:Enabling-the-Business-of-Agriculture, 2016-11-17/2017-04-15.
[74] Atrey A. Summary and Conclusions of Global Animal Health Conference [EB/OL]. https://healthforanimals.org/component/attachments/?task=download&id=248:Summary-and-Conclusions-of-Global-Animal-Health-Conference, 2016-11-17/2017-04-16.
[75] US FDA. Regulatory Perspectives – Challenges and Opportunities [EB/OL]. https://olathe.k-state.edu/professional-dev/workshops/regulatory-affairs/documents/sept17/FinalKansasSept2017.sent%20to%20KState9.13.17.pdf, 2017-09-24/2018-06-06.
[76] Argento E. Case Study on regional harmonization initiatives in America. CAMEVET [EB/OL]. https://healthforanimals.org/resources-and-events/resources/events/2-5th-global-animal-health-conference.html, 2016-11-17/2017-09-17.
81
[77] Cordeiro B. Case Study Latin America [EB/OL]. https://healthforanimals.org/component/attachments/?task=download&id=243:Case-Study-Latin-America, 2016-11-17/2017-09-17.
[78] Harvey J. What changes does the European regulatory framework need? [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/, 2016-06-29/2017-09-18.
[79] Harvey J. European industry welcomes progress made on vaccine availability [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/, 2017-03-24/2017-09-18.
[80] ASEAN National Focal Points on Veterinary Product. ASEAN Cooperation on Veterinary Products & ASEAN Registration of Animal Vaccine [EB/OL]. http://www.oie.int/fileadmin/Home/eng/Our_scientific_expertise/docs/pdf/VICH/Minutes_Tokyo2017.pdf, 2017-11-15/2018-08-23.
[81] Asian regulatory landscape A strategic overview [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP003841/Asian-regulatory-landscape-A-strategic-overview, 2014-04-02/2017-08-14.
[82] HealthforAnimals. Global Animal Health Workshop 2017. Good Regulatory Practice for the Marketing Authorisation of Veterinary Products in an African Context [EB/OL]. http://www.rr-africa.oie.int/docspdf/en/2017/Report_GAHW_2017.pdf, 2017-06-14/2018-05-30.
[83] Singh S.N. Regulatory Status of Veterinary Medicinal Products (VMPs) - An Indian Perspective [EB/OL]. https://healthforanimals.org/component/attachments/?task=download&id=247:Regulatory-Status-of-Veterinary-Medicinal-Products-(VMPs)---An-Indian-Perspective, 2016-11-17/2017-09-23.
[84] Harvey J. Regulatory improvements are required to ease India's access to veterinary medicines [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/, 2016-11-25/2017-10-12.
[85] 王忠田,曲鸿飞,王乐元. 兽用生物制品评审工作面临的主要问题及对策[J]. 中国兽药杂志2017. 51 (6): 74-77.
[86] Harvey J. What are the main obstacles in the Chinese vet med regulation process? [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP008225/What-are-the-main-obstacles-in-the-Chinese-vet-med-regulation-process, 2015-03-04/2017-09-28.
[87] Harvey J. China's animal health firms struggle with pace of domestic regulatory change [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/AP014226/Chinas-
82
animal-health-firms-struggle-with-pace-of-domestic-regulatory-change, 2018-06-12/2018-07-01.
[88] HealthforAnimals. Vision for regulation of veterinary medicines across the world [EB/OL]. https://healthforanimals.org/resources-and-events/resources/publications/158-vision-for-regulation-of-veterinary-medicines-across-the-world.html, 2016-09-01/2017-04-28.
[89] Gifford G. Regulatory Convergence for Animal Health Products: Ojective, benefits, and approaches to implementation [EB/OL]. https://healthforanimals.org/component/attachments/?task=download&id=282:Session_2, 2017-06-06/2018-01-29.
[90] Leivers M. Optimizing the Regulatory Framework [EB/OL]. https://healthforanimals.org/component/attachments/?task=download&id=241:Optimising-the-Regulatory-Framework, 2016-11-17/2018-02-24.
[91] Cowan G. Authorization Procedures [EB/OL]. https://healthforanimals.org/component/attachments/?task=download&id=255:Session-4---Authorisation-Procedures, 2016-11-17/2018-02-25.
[92] Swaziland E. Recommendations of the joint GALVMED / OIE workshop on Harmonisation of the registration of veterinary medicinal products in the SADC region: Industry’s perspective [EB/OL]. http://www.rr-africa.oie.int/docspdf/en/2017/EZUL/SABOT1.pdf, 2017-12-08/2018-0-19.
[93] Harvey J. Brazil aims to reduce its "excessive regulatory bureaucracy' [EB/OL]. https://animalpharm.agribusinessintelligence.informa.com/, 2016-11-29/2017-07-29.
[94] Bobey M.C. Harmonization of regulatory guidelines on efficacy of ectoparasiticides for companion animals: status and missing points [J]. Veterinary Parasitology. 2015, 208 (1-2): 48-55.
[95] Lainesse C. International Veterinary Bioequivalence Guideline Similarities and Differences Between Australia, Canada, Europe, Japan, New Zealand and the United States [J]. America Association of Pharmaceutical Scientists Journal. 2012, 14 (4): 792-798.
[96] John S.A. Ridder E.D. Global regulatory strategy for veterinary medicines [J]. Rapporteur. 2014. 11 (1): 20-22.
[97] 华北制药集团动物保健品有限责任公司. 新兽药研发之变革[EB/OL]. http://www.ncpcdb.com/jishu/2017-12-12/514.html, 2017-12-05/2018-06-20.
[98] Harvey J. Brazilian government pledges to reduce regulatory backlog with industry help [EB/OL].
83
https://animalpharm.agribusinessintelligence.informa.com/AP014173/Brazilian-government-pledges-to-reduce-regulatory-backlog-with-industry-help, 2018-05-31/2018-06-18.
[99] Dolan, Robert J. Note on Marketing Strategy. Harvard Business School Background Note 598-061 [EB/OL]. https://www.hbs.edu/faculty/Pages/item.aspx?num=20296, 2000-11-01/2018-09-01.
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
* *